19 results on '"Yi-Ming Zhou"'
Search Results
2. Autophagy is activated in the ovarian tissue of polycystic ovary syndrome.
- Author
-
Da Li, Yue You, Fang-Fang Bi, Tie-Ning Zhang, Jiao Jiao, Tian-Ren Wang, Yi-Ming Zhou, Zi-Qi Shen, Xiu-Xia Wang, and Qing Yang
- Subjects
POLYCYSTIC ovary syndrome ,TRANSMISSION electron microscopy ,REGRESSION analysis ,FUNCTIONAL analysis ,GENETICS ,DISEASE risk factors - Abstract
The importance of autophagy in polycystic ovary syndrome (PCOS)-related metabolic disorders is increasingly being recognized, but few studies have investigated the role of autophagy in PCOS. Here, transmission electron microscopy demonstrated that autophagy was enhanced in the ovarian tissue from both humans and rats with PCOS. Consistent with this, ovarian granulosa cells from PCOS rats showed increases in the autophagy marker protein light chain 3B (LC3B), whereas levels of the autophagy substrate SQSTM1/p62 were decreased. In addition, the ratio of LC3-II/LC3-I was markedly elevated in human PCOS ovarian tissue compared with normal ovarian tissue. Real-time PCR arrays indicated that 7 and 34 autophagy-related genes were down- and up-regulated in human PCOS , Signal-Net, and regression analysis suggested that there are a wide range of interactions among these 41 genes and a potential network based on EGFR, ERBB2, FOXO1, MAPK1, NFKB1, IGF1, TP53 and MAPK9 may be responsible for autophagy activation in PCOS. Systematic functional analysis of 41 differential autophagy-related genes indicated that these genes are highly involved in specific cellular processes such as response to stress and stimulus and are linked to four significant pathways, including the insulin, ERBB, mTOR signaling pathways and protein processing in the endoplasmic reticulum. This study provides evidence for a potential role of autophagy disorders in PCOS in which autophagy may be an important molecular event in the pathogenesis of PCOS. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
3. The Anti-Allergic Rhinitis Effect of Traditional Chinese Medicine of Shenqi by Regulating Mast Cell Degranulation and Th1/Th2 Cytokine Balance.
- Author
-
Yang-Yang Shao, Yi-Ming Zhou, Min Hu, Jin-Ze Li, Cheng-Juan Chen, Yong-Jiang Wang, Xiao-Yun Shi, Wen-Jie Wang, and Tian-Tai Zhang
- Subjects
ANTIALLERGIC agents ,RHINITIS ,CHINESE medicine ,MAST cells ,CYTOKINES ,OVALBUMINS - Abstract
Shenqi is a traditional Chinese polyherbal medicine has been widely used for the treatment of allergic rhinitis (AR). The aim of this study was to investigate the anti-allergic rhinitis activity of Shenqi and explore its underlying molecular mechanism. Ovalbumin (OVA)-induced allergic rhinitis rat model was used to evaluate the anti-allergic rhinitis effect of Shenqi. The effect of Shenqi on IgE-mediated degranulation was measured using rat basophilic leukemia (RBL-2H3) cells. Primary spleen lymphocytes were isolated to investigate the anti-allergic mechanism of Shenqi by detecting the expression of transcription factors viaWestern blot and the level of cytokines (IL-4 and IFN-) via ELISA. In OVA-induced AR rat models, Shenqi relieved the allergic rhinitis symptoms, inhibited the histopathological changes of nasal mucosa, and reduced the levels of IL-4 and IgE. The results from the in vitro study certified that Shenqi inhibited mast cell degranulation. Furthermore, the results of GATA3, T-bet, p-STAT6, and SOCS1 expression and production of IFN- and IL-4 demonstrated that Shenqi balanced the ratio of Th1/Th2 (IFN-γ/IL-4) in OVA-stimulated spleen lymphocytes. In conclusion, these results suggest that Shenqi exhibits an obvious anti-allergic effect by suppressing the mast cell-mediated allergic response and by improving the imbalance of Th1/Th2 ratio in allergic rhinitis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Effects of receptor for advanced glycation endproducts on microvessel formation in endometrial cancer.
- Author
-
Lu Zheng, Da Li, Yi-Ming Zhou, Hui Yang, Di Cheng, Xiao-Xin Ma, Zheng, Lu, Li, Da, Zhou, Yi-Ming, Yang, Hui, Cheng, Di, and Ma, Xiao-Xin
- Subjects
ADVANCED glycation end-products ,ENDOMETRIAL cancer ,CANCER invasiveness ,GENE expression ,SMALL interfering RNA ,XENOGRAFTS ,ANIMAL experimentation ,BLOOD vessels ,CELL lines ,CELL physiology ,GENES ,GENETIC techniques ,MICE ,TRANSFERASES ,TUMOR antigens ,ENDOMETRIAL tumors - Abstract
Background: The receptor for advanced glycation endproducts (RAGE) and microvascular status both play a critical role in cancer progression. However, the crosstalk between RAGE and microvascular formation in endometrial cancer remains largely unknown.Methods: RAGE expression and microvessel density were examined in 20 cases of normal endometrial tissue, 37 cases of well-differentiated endometrial cancer tissue, and 35 cases of poorly-differentiated endometrial cancer tissue. Regression analysis was used to examine the relationship between RAGE and microvessel density. The knockdown of RAGE was achieved using a small interfering RNA in HEC-1A endometrial cancer cells. A xenografted tumour model was used to evaluate RAGE-mediated microvascular formation and proliferation of endometrial cancer cells.Results: It was shown that (i) RAGE expression gradually increased in normal endometrium, well-differentiated endometrial cancer, and poorly-differentiated endometrial cancer, respectively; (ii) a positive correlation existed between RAGE and microvessel density in human endometrial cancer samples; (iii) RAGE knockdown was effective in decreasing microvessel formation in xenografted tumour models; and (iv) RAGE knockdown can significantly inhibit the proliferation of endometrial cancer cells in vivo.Conclusions: These results indicate that RAGE may be a potential trigger in microvascular formation and proliferation in the development of endometrial cancer. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
5. Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic.
- Author
-
Hai-nan Zhang, Lina Yang, Jian-ya Ling, Czajkowsky, Daniel M., Jing-Fang Wang, Xiao-Wei Zhang, Yi-Ming Zhou, Feng Ge, Ming-kun Yang, Qian Xiong, Shu-Juan Guo, Huang-Ying Le, Song-Fang Wu, Wei Yan, Bingya Liu, Zhu Chen, Sheng-ce Tao, and Heng Zhu
- Subjects
ARSENIC compounds ,CARRIER proteins ,GLUCOKINASE ,LEUKEMIA treatment ,ANTINEOPLASTIC agents - Abstract
Arsenic is highly effective for treating acute promyelocytic leukemia (APL) and has shown significant promise against many other tumors. However, although its mechanistic effects in APL are established, its broader anticancer mode of action is not understood. In this study, using a human proteome microarray, we identified 360 proteins that specifically bind arsenic. Among the most highly enriched proteins in this set are those in the glycolysis pathway, including the rate-limiting enzyme in glycolysis, hexokinase-1. Detailed biochemical and metabolomics analyses of the highly homologous hexokinase-2 (HK2), which is overexpressed in many cancers, revealed significant inhibition by arsenic. Furthermore, overexpression of HK2 rescued cells from arsenic-induced apoptosis. Our results thus strongly implicate glycolysis, and HK2 in particular, as a key target of arsenic. Moreover, the arsenic-binding proteins identified in this work are expected to serve as a valuable resource for the development of synergistic antitumor therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. YcgC represents a new protein deacetylase family in prokaryotes.
- Author
-
Shun Tu, Shu-Juan Guo, Chien-Sheng Chen, Cheng-Xi Liu, He-Wei Jiang, Feng Ge, Jiao-Yu Deng, Yi-Ming Zhou, Czajkowsky, Daniel M., Yang Li, Bang-Ruo Qi, Young-Hoon Ahn, Cole, Philip A., Heng Zhu, and Sheng-Ce Tao
- Published
- 2015
- Full Text
- View/download PDF
7. Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients.
- Author
-
Xiao-Dong Gu, Yan-Tao Cai, Yi-Ming Zhou, Zhen-Yang Li, Jian-Bin Xiang, Zong-You Chen, Gu, Xiao-Dong, Cai, Yan-Tao, Zhou, Yi-Ming, Li, Zhen-Yang, Xiang, Jian-Bin, and Chen, Zong-You
- Subjects
BRAIN metastasis ,TREATMENT of brain cancer ,COLON cancer patients ,CANCER prognosis ,CANCER radiotherapy ,BRAIN tumor treatment ,AGE distribution ,BRAIN tumors ,COLON tumors ,COMBINED modality therapy ,PROGNOSIS ,RECTUM tumors ,RETROSPECTIVE studies ,KAPLAN-Meier estimator ,KARNOFSKY Performance Status - Abstract
Background: The purpose of this study was to review patient characteristics and evaluate the potential factors affecting prognosis in cases of brain metastasis (BM) from colorectal cancer (CRC).Methods: We retrospectively reviewed 93 cases of BM from CRC in our hospital. Patient demographics, neurologic symptoms, and location and number of BMs were recorded. Factors analyzed included: age; sex; Karnofsky performance score; number of BMs; presence of extracranial metastases; dimensions; location of tumors; treatment modalities.Results: The overall 1- and 2-year survival rates were 27.7 and 9.9%. On multivariate analysis, the number of BMs, extracranial metastases and the initial treatment modalities were found to be independent prognostic factors for overall survival. Patients treated with surgical resection followed by WBRT or SRS had an improved prognosis relative to those treated with surgery alone (P=0.02 and P=0.02, respectively). No significance difference in survival rate was found between patients treated with SRS alone or SRS plus WBRT (P=0.11).Conclusions: Surgical resection of BMs from CRC in selected patients may help prolong survival. Additional radiotherapy following surgery is valuable in improving prognosis. Extracranial metastasis, multiple BM lesions and initial non operation can be considered as independent factors associated with poor prognosis. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
8. Measuring sentence similarity from different aspects.
- Author
-
Lin Li, Xia Hu, Bi-Yun Hu, Jun Wang, and Yi-Ming Zhou
- Published
- 2009
- Full Text
- View/download PDF
9. Relatedness measurement for news items.
- Author
-
Lin Li, Xia Hu, Chao Xu, and Yi Ming Zhou
- Published
- 2008
- Full Text
- View/download PDF
10. Measuring semantic similarity within sentences.
- Author
-
Xiao-Ying Liu, Yi-Ming Zhou, and Ruo-Shi Zheng
- Published
- 2008
- Full Text
- View/download PDF
11. Measuring Semantic Similarity in Wordnet.
- Author
-
Xiao-Ying Liu, Yi-Ming Zhou, and Ruo-Shi Zheng
- Published
- 2007
- Full Text
- View/download PDF
12. Wavelet-based hierarchical document categorization.
- Author
-
Chao Xu and Yi-Ming Zhou
- Published
- 2007
- Full Text
- View/download PDF
13. A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer.
- Author
-
Da Li, Fang-Fang Bi, Na-Na Chen, Ji-Min Cao, Wu-Ping Sun, Yi-Ming Zhou, Chun-Yan Li, and Qing Yang
- Subjects
OVARIAN cancer ,NICOTINAMIDE nucleotides ,GENE expression ,ENERGY metabolism ,METHYLATION - Abstract
BRCA mutations are the main known hereditary factors for ovarian cancer. Notably, emerging evidence has led to considerable interest in the role of sirtuin 1 (SIRT1) in ovarian cancer development. However, dynamic crosstalk between BRCA1 and SIRT1 is poorly understood. Here, we showed that: (i) BRCA1 inactivation events (mutation, promoter methylation, or knockdown) were accompanied by decreased SIRT1 levels and increased nicotinamide adenine dinucleotide (NAD) levels and a subsequent increase in SIRT1 activity; (ii) overexpression of BRCA1 resulted in increased SIRT1 levels, an impairment in NAD synthesis, and a subsequent inhibition of SIRT1 activity; and (iii) intracellular NAD levels were largely responsible for regulating SIRT1 activity, and BRCA1 expression patterns correlated with SIRT1 levels and NAD levels correlated with SIRT1 activity in human ovarian cancer specimens. Interestingly, although BRCA1 inactivation events inhibited SIRT1 expression, they led to a substantial increase in NAD levels that enhanced NAD-related SIRT1 activity. This is a special BRCA1-mediated compensatory mechanism for the maintenance of SIRT1 function. Therefore, these results highlight a novel interaction between BRCA1 and SIRT1, which may be beneficial for the dynamic balance between BRCA1-related biologic processes and SIRT1-related energy metabolism and stress response. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer.
- Author
-
Da Li, Na-Na Chen, Ji-Min Cao, Wu-Ping Sun, Yi-Ming Zhou, Chun-Yan Li, and Xiu-Xia Wang
- Published
- 2014
- Full Text
- View/download PDF
15. Early Infant Exposure to Excess Multivitamin: A Risk Factor for Autism?
- Author
-
Shi-Sheng Zhou, Yi-Ming Zhou, Da Li, and Qiang Ma
- Abstract
Autism, a neurodevelopmental disorder that affects boys more than girls, is often associated with altered levels of monoamines (serotonin and catecholamines), especially elevated serotonin levels. The monoamines act as both neurotransmitters and signaling molecules in the gastrointestinal and immune systems. The evidence related to monoamine metabolism may be summarized as follows: (i) monoamine neurotransmitters are enzymatically degraded/inactivated by three mechanisms: oxidative deamination, methylation, and sulfation. The latter two are limited by the supply of methyl groups and sulfate, respectively. (ii) A decrease in methylation- and sulfation-mediated monoamine inactivation can be compensated by an increase in the oxidative deamination catalyzed by monoamine oxidase, an X-linked enzyme exhibiting higher activity in females than in males. (iii) Vitamins can, on one hand, facilitate the synthesis of monoamine neurotransmitters and, on the other hand, inhibit their inactivation by competing for methylation and sulfation. Therefore, we postulate that excess multivitamin feeding in early infancy, which has become very popular over the past few decades, may be a potential risk factor for disturbed monoaminemetabolism. In this paper, we will focus on the relationship between excess multivitamin exposure and the inactivation/degradation of monoamine neurotransmitters and its possible role in the development of autism. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
16. Inhibition of Arterial Allograft Intimal Hyperplasia Using Recipient Dendritic Cells Pretreated with B7 Antisense Peptide.
- Author
-
Yu-Feng Yao, Yi-Ming Zhou, Jian-Bin Xiang, Xiao-Dong Gu, and Duan Cai
- Subjects
HOMOGRAFTS ,HYPERPLASIA ,DENDRITIC cells ,ANTISENSE peptides ,LABORATORY mice ,BONE marrow cells - Abstract
Background. Low expression or absence of dendritic cell (DC) surface B7molecules can induce immune tolerance or hyporesponse. Whether DCs could induce indirect allogeneic-specific cross-tolerance or hyporesponse to recipient T cells remains unclear. Methods. Generated from C3H/He mice bone marrow cells pulsed with donor antigen from C57BL/6 mice, recipient DCs were incubated with B7 antisense peptide (B7AP). Immune regulatory activities were examined in vitro by a series of mixed lymphocyte reactions. Murine allogeneic carotid artery orthotopic transplantation was performed from C57BL/6 to C3H/He. Recipients were given B7AP-treated DCs 7 days before transplantation. Allograft pathological analysis was done 2 months after transplantation. Results. B7AP-pretreated DCs markedly inhibited T-cell proliferation compared with untreated group. Pretreated T cells exhibited markedly reduced response to alloantigen versus third-party antigen. Pathological analysis of arterial allografts demonstrated significant reduction of intimal hyperplasia in B7-AP pretreated group versus control. Conclusion. Blockade of B7 molecules by B7AP could induce indirect allogeneic-specific hyporesponse and inhibit arterial allograft intimal hyperplasia, which may be involved in future strategies for human allograft chronic rejection. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
17. The skin function: a factor of anti-metabolic syndrome.
- Author
-
Shi-Sheng Zhou, Da Li, Yi-Ming Zhou, and Ji-Min Cao
- Subjects
METABOLIC syndrome ,INSULIN resistance ,METABOLIC disorders ,ANTIOXIDANTS ,EXOCRINE glands - Abstract
The body's total antioxidant capacity represents a sum of the antioxidant capacity of various tissues/organs. A decrease in the body's antioxidant capacity may induce oxidative stress and subsequent metabolic syndrome, a clustering of risk factors for type 2 diabetes and cardiovascular disease. The skin, the largest organ of the body, is one of the major components of the body's total antioxidant defense system, primarily through its xenobiotic/drug biotransformation system, reactive oxygen species-scavenging system, and sweat glands- and sebaceous glands-mediated excretion system. Notably, unlike other contributors, the skin contribution is variable, depending on lifestyles and ambient temperature or seasonal variations. Emerging evidence suggests that decreased skin's antioxidant and excretory functions (e.g., due to sedentary lifestyles and low ambient temperature) may increase the risk for metabolic syndrome. This review focuses on the relationship between the variability of skin-mediated detoxification and elimination of exogenous and endogenous toxic substances and the development of metabolic syndrome. The potential role of sebum secretion in lipid and cholesterol homeostasis and its impact on metabolic syndrome, and the association between skin disorders (acanthosis nigricans, acne, and burn) and metabolic syndrome are also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
18. B-vitamin consumption and the prevalence of diabetes and obesity among the US adults: population based ecological study.
- Author
-
Shi-Sheng Zhou, Da Li, Yi-Ming Zhou, Wu-Ping Sun, and Qi-Gui Liu
- Subjects
VITAMIN B deficiency ,PEOPLE with diabetes ,DIABETES ,NUTRITION disorders ,OBESITY ,OVERWEIGHT persons - Abstract
Background: The global increased prevalence of obesity and diabetes occurred after the worldwide spread of Bvitamins fortification, in which whether long-term exposure to high level of B vitamins plays a role is unknown. Our aim was to examine the relationships between B-vitamins consumption and the obesity and diabetes prevalence. Methods: This population based ecological study was conducted to examine possible associations between the consumption of the B vitamins and macronutrients and the obesity and diabetes prevalence in the US population using the per capita consumption data from the US Economic Research Service and the prevalence data from the US Centers for Disease Control and Prevention. Results: The prevalences of diabetes and adult obesity were highly correlated with per capita consumption of niacin, thiamin and riboflavin with a 26-and 10-year lag, respectively (R² = 0.952, 0.917 and 0.83 for diabetes, respectively, and R² = 0.964, 0.975 and 0.935 for obesity, respectively). The diabetes prevalence increased with the obesity prevalence with a 16-year lag (R² = 0.975). The relationships between the diabetes or obesity prevalence and per capita niacin consumption were similar both in different age groups and in male and female populations. The prevalence of adult obesity and diabetes was highly correlated with the grain contribution to niacin (R² = 0.925 and 0.901, respectively), with a 10-and 26-year lag, respectively. The prevalence of obesity in US adults during 1971-2004 increased in parallel with the increase in carbohydrate consumption with a 10-year lag. The per capita energy and protein consumptions positively correlated with the obesity prevalence with a one-year lag. Moreover, there was an 11-year lag relationship between per capita energy and protein consumption and the consumption of niacin, thiamin and riboflavin (R² = 0.932, 0.923 and 0.849 for energy, respectively, and R² = 0.922, 0.878 and 0.787 for protein, respectively). Conclusions: Long-term exposure to high level of the B vitamins may be involved in the increased prevalence of obesity and diabetes in the US in the past 50 years. The possible roles of B-vitamins fortification and excess niacin consumption in the increased prevalence of obesity and diabetes were discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
19. Effects of monocarboxylic acid-derived Cl− channel blockers on depolarization-activated potassium currents in rat ventricular myocytes.
- Author
-
Shi-Sheng Zhou, Li-Bin Zhang, Wu-Ping Sun, Fu-Cheng Xiao, Yi-Ming Zhou, Ya-Jie Li, and Dong-Liang Li
- Subjects
CARBOXYLIC acids ,ORGANIC acids ,CALCIUM antagonists ,HEART ,LABORATORY rats - Abstract
The effects of monocarboxylic acid-derived Cl
− channel blockers on cardiac depolarization-activated K+ currents were investigated. Membrane currents in rat ventricular myocytes were recorded using the whole-cell configuration of the patch-clamp technique. 5-Nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) and niflumic acid (NFA) induced an outward current at 0 mV. Both NPPB and NFA failed to induce any current when used intracellularly or after K+ in the bath and pipette solutions was replaced by equimolar Cs+ . Voltage pulse protocols revealed that NPPB and NFA enhanced the steady-state K+ current but inhibited the transient outward K+ current. Genistein, a tyrosine kinase (PTK) inhibitor, inhibited NPPB- and NFA-induced outward current. Another PTK inhibitor, lavendustin A, produced a comparable effect. In contrast, the inactive analogue of genistein, daidzein, was ineffective. Orthovanadate, a tyrosine phosphatase inhibitor, markedly slowed the deactivation of the outward current induced by NPPB and NFA. The protein kinase A (PKA) inhibitor H-89 inhibited NPPB-induced outward current at 0 mV. In contrast, the protein kinase C (PKC) inhibitor H-7 was without significant effect on the action of NPPB. Pretreatment of the myocytes with genistein or H-89 prevented the enhancing effect of NPPB. Increasing intracellular Cl− from 22 to 132 mm slightly reduced NPPB-induced outward current at 0 mV. These results demonstrate that the monocarboxylic acid-derived Cl− channel blockers NPPB and NFA enhance cardiac steady-state K+ current, and suggest that the enhancing effect of the Cl− channel blockers is mediated by stimulation of PKA and PTK signalling pathways. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.